Ryzodeg FlexTouch 100 U/mL Pen | Insulin Sugar Control

Drug Overview

Ryzodeg FlexTouch 100 Units is a prefilled insulin pen used to support blood glucose control in people with diabetes mellitus. It contains a dual insulin formulation that combines rapid-acting and ultra-long-acting insulin to help manage blood sugar levels throughout the day. Ryzodeg FlexTouch is designed for accurate dosing, flexible use under medical supervision, and convenient subcutaneous injection.

Active Ingredient and Composition

• Insulin degludec 70%
• Insulin aspart 30%
• Strength: 100 units/mL
• Pharmaceutical form: Prefilled insulin pen
• Pack size: 5 pens
• Volume per pen: 3 mL

This product is a dual insulin combination that provides both mealtime and basal insulin coverage in a single pen.

Drug Class

Ryzodeg belongs to the class of:

• Antidiabetic medicines
• Insulin analog combinations

It is considered a biphasic insulin product used for glycemic control in appropriate patients with diabetes.

Uses and Medical Indications of Ryzodeg FlexTouch

• Controlling high blood sugar levels
• Treatment of type 1 diabetes mellitus
• Treatment of type 2 diabetes mellitus
• Supporting more stable glucose control during the day
• Providing flexible insulin dosing as directed by a physician

This insulin pen is used as part of a broader diabetes care plan that includes blood glucose monitoring, nutrition, and physical activity.

How Ryzodeg FlexTouch Works

Ryzodeg FlexTouch works through two insulin components with complementary actions. Insulin aspart provides rapid blood sugar lowering around meals, while insulin degludec delivers prolonged basal insulin coverage. This dual mechanism helps reduce glucose fluctuations, improve overall glycemic stability, and support daily diabetes management.

Dosage and Administration

• The dose is determined individually based on blood glucose readings, medical condition, and insulin needs
• It is administered by subcutaneous injection using the prefilled pen
• It may be used once or twice daily depending on the treatment plan
• Dose adjustment should be made gradually according to clinical response
• Do not change the dose or stop treatment without medical advice
• Use only according to the physician’s instructions

Possible Side Effects

Possible side effects may include:

• Hypoglycemia (low blood sugar), which is the most common insulin-related adverse effect
• Dizziness
• Sweating
• Injection site redness or irritation
• Weight gain in some patients

Any severe or persistent symptoms should be discussed with a healthcare professional.

Contraindications

• Patients with known hypersensitivity to insulin degludec, insulin aspart, or any component of the formula
• Situations where insulin therapy is not appropriate without medical supervision

Drug Interactions

Insulin degludec/aspart may interact with other medicines that affect blood glucose levels. These may include:

• Other antidiabetic medicines
• Drugs that may increase the risk of hypoglycemia
• Drugs that may reduce or enhance the effect of insulin

Patients should inform their doctor about all prescription medicines, over-the-counter products, and supplements they use.

Warnings and Precautions

• Monitor blood glucose regularly during treatment
• Use cautiously in patients with kidney or liver impairment
• Dose adjustments may be needed when changing diet, exercise, or daily routine
• Learn the symptoms of low blood sugar and how to respond quickly
• Use the pen correctly and follow injection guidance carefully

Use During Pregnancy and Breastfeeding

The provided content does not include detailed pregnancy or breastfeeding instructions. Insulin treatment during pregnancy or lactation should always be guided by a physician to ensure safe and appropriate glucose control.

Use for Children

The source content does not provide specific pediatric guidance. Use in children should follow the treating physician’s recommendations and individualized insulin planning.

Drug Alternatives

• Other insulin analog combinations
• Basal insulin with separate rapid-acting insulin regimens
• Other prefilled insulin pens depending on the patient’s diabetes plan

The appropriate alternative depends on the type of diabetes, glucose profile, lifestyle, and physician assessment.

Comparison With Similar Drugs

Compared with single-action insulin products, Ryzodeg FlexTouch offers a combined approach by delivering both rapid mealtime insulin and long-acting basal insulin in one formulation. This may simplify treatment for some patients who need both types of insulin support.

Safe Usage Tips

• Check your blood sugar as advised
• Follow a healthy diabetes meal plan
• Stay physically active on a regular basis
• Carry a fast source of sugar in case of hypoglycemia
• Take injections at the prescribed times
• Store the pen correctly and never freeze it

Conclusion

Ryzodeg FlexTouch 100 Units is a dual-action insulin pen that combines insulin degludec and insulin aspart to help control blood sugar levels in diabetes. When used correctly, Ryzodeg supports more stable glucose management and practical daily insulin delivery.